LENSAR, Inc.
NASDAQ:LNSRMedical - Devices
-$0.51 today
- Market cap
- $59.63M
- Beta
- 0.87
- P/E (TTM)
- 2.4
- EPS (TTM)
- $2.42
Volume 0.06M
Average 0.09M
LNSR Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
LENSAR, Inc.NASDAQ: LNSR
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit declines year over year
Q1 FY2026 gross profit of $6.38M fell 10.4% year over year, behind the -3.4% change in trailing-twelve-month gross profit. Sequentially, it fell 8.0% from the prior quarter. Over 3 fiscal years it compounded at +10.8% a year.
Context
- Gross profit amounted to 46.4% of revenue in FY2025, down 1.9 pp from a year earlier.
- Gross profit increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -10.4% toward the trailing-twelve-month pace of -3.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 27.12M USD
- Year-over-year change
- +4.9%
- 4-year CAGR
- +11.1%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 27.12M | +4.9% |
| FY2024 | 2024-12-31 | 25.85M | +22.5% |
| FY2023 | 2023-12-31 | 21.11M | +5.8% |
| FY2022 | 2022-12-31 | 19.96M | +11.9% |
| FY2021 | 2021-12-31 | 17.83M | — |
Gross Profit vs competitors
How LNSR compares with its peers on the latest reported figures
- LNSR's LTM Mar 2026 gross profit of $26.15M is the 4th highest of the 10 companies compared; the peer median is $13.41M.
- Its year-over-year change of -3.4% is the 7th highest of 10, against a peer median of +23.4%.
- Gross profit amounts to 45.3% of revenue for LNSR, versus a peer median of 64.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $68.12M | +15.1% | -4.5% | 58.6% | |
| LTM Mar 2026 | $54.45M | +23.4% | +31.9% | 50.9% | |
| LTM Mar 2026 | $38.18M | +38.8% | +55.6% | 85.1% | |
| LTM Mar 2026 | $26.15M | -3.4% | +10.8% | 45.3% | |
| LTM Mar 2026 | $26.06M | -14.5% | -11.9% | 80.7% | |
| LTM Mar 2026 | $13.41M | +43.6% | +56.6% | 71.1% | |
| LTM Mar 2026 | $4.26M | +134.5% | — | 12.4% | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | $523K | -60.4% | — | 28.3% |
| LTM Mar 2026 | -$149K | +99.1% | — | — | |
| LTM Mar 2026 | -$11.06M | -20.7% | +15.4% | 2105.7% | |
| Peer median (excluding LNSR) | $13.41M | +23.4% | +23.7% | 64.8% | |
Competitors are the stored peer set for LNSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 34.46M | 35.36M | 42.16M | 53.49M | 58.44M |
| Cost of Revenue | 16.63M | 15.4M | 21.06M | 27.64M | 31.31M |
| Gross Profit | 17.83M | 19.96M | 21.11M | 25.85M | 27.12M |
| Gross Margin | 51.8% | 56.4% | 50.1% | 48.3% | 46.4% |
| Research & Development | 12.36M | 11.81M | 6.14M | 5.33M | 5.62M |
| Selling, General & Admin | 23.89M | 27.17M | 26.1M | 26.49M | 45.16M |
| Operating Expenses | 37.49M | 40.13M | 33.34M | 36.52M | 51.7M |
| Depreciation & Amortization | 2.76M | 3.41M | 3.52M | 3.93M | 4.5M |
| EBITDA | (16.84M) | (16.51M) | (10.87M) | (3.01M) | (29.78M) |
| EBITDA Margin | -48.9% | -46.7% | -25.8% | -5.6% | -51.0% |
| Operating Income | (19.65M) | (20.18M) | (12.23M) | (10.67M) | (24.58M) |
| Operating Margin | -57.0% | -57.1% | -29.0% | -19.9% | -42.1% |
| Interest Income | 34K | 17K | 85K | 103K | 91K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 51K | 263K | (2.15M) | (20.74M) | (9.7M) |
| Income Before Tax | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Pre-Tax Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (19.6M) | (19.91M) | (14.38M) | (31.4M) | (34.28M) |
| Net Margin | -56.9% | -56.3% | -34.1% | -58.7% | -58.7% |
| EPS (Basic) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| EPS (Diluted) | (2.10) | (1.96) | (1.31) | (2.73) | (2.87) |
| Weighted Avg Shares | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
| Weighted Avg Shares (Diluted) | 9.37M | 10.16M | 10.97M | 11.52M | 11.96M |
LENSAR, Inc.
NASDAQ:LNSR
Intrinsic Alpha fair value
Locked
Current Price
$4.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.